– Illustrative image from U.S. Patent No. 7,483,747
Today we highlight a key brain stimulation patent assigned to Advanced Neuromodulation Systems. (As mentioned, we are featuring a foundational Pervasive Neurotech patent a day, from older to newer by issue date)
U.S. Patent No. 7,483,747: Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy.
- Assignee(s): Advanced Neuromodulation Systems, Inc.
- Inventor(s): Bradford Evan Gliner, Allen Wyler, Brad Fowler, W. Douglas Sheffield, Richard Kuntz, Kent Leyde, Leif R. Sloan
- Technology Category: Transcranial Stimulation
- Issue Date: January 27, 2009
The ‘747 patent discloses methods for improving efficacy and efficiency of brain stimulation by providing two distinct phases of electromagnetic stimulation that vary from one another in parameters such as time of stimulation, amplitude of signal, location of treatment, frequency of pulse, etc. Read the rest of this entry »
How Thync, Startup Behind Brain-Zapping Gadget, Almost Died (Bloomberg):
“In 2014, Silicon Valley startup Thync had sold technology enthusiasts and venture capitalists on the idea of strapping a device to your forehead that sends electric shocks to the brain. The wearable gadget garnered attention for its futuristic promises of brain stimulation, Read the rest of this entry »
— TNT technology will be designed to safely and precisely modulate peripheral nerves to control synaptic plasticity during cognitive skill training.
Boosting Synaptic Plasticity to Accelerate Learning (DARPA news):
“The body’s branching network of peripheral nerves connects neurons in the brain and spinal cord to organs, skin, and muscles, regulating a host of biological functions from digestion to sensation to locomotion. But the peripheral nervous system can do even more than that…pushing those limits further, DARPA aims to enlist the body’s peripheral nerves to achieve something that has long been considered the brain’s domain alone: facilitating learning. Read the rest of this entry »
Neosync is an early stage company developing a new treatment for major depression based on Transcranial Magnetic Stimulation (TMS). The treatment–named NEST (Neosync EEG Synchronized TMS) and undergoing clinical trials–is based on the idea that depression patients tend to have overly rhythmic brain activity, Read the rest of this entry »
LifeWatch is a provider of ambulatory health monitoring solutions that help physicians and users detect early symptoms across a range of conditions, primarily by leveraging ECG (heart rate monitoring) technology. Read the rest of this entry »